As a clinical-stage, biopharmaceutical company, we develop innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology. ... <看更多>
「cyclacel pharmaceuticals, inc investor relations」的推薦目錄：
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Release First ... - Yahoo Finance 的相關結果
About Cyclacel Pharmaceuticals, Inc. ... Investor Relations: ... logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCCP - Cyclacel Pharmaceuticals Inc - 相關新聞 - 基金- 鉅亨 的相關結果
鉅亨美股頻道提供你最完整的CYCCP - Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL ... 2023 16:30 ET Company Participants Irina Koffler - Investor Relations ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Release First Quarter ... - Moomoo 的相關結果
Investor Relations : Grace Kim, [email protected] ... The Cyclacel logo and Cyclacel are trademarks of Cyclacel Pharmaceuticals, Inc. This presentation is for ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Reports First Quarter Financial ... 的相關結果
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update - Key Catalysts ahead with multiple Value ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Underwritten Offering - SEC.gov 的相關結果
Contacts for Cyclacel Pharmaceuticals, Inc. Company: Paul McBarron, (908) 517-7330, [email protected]. Investor Relations: Russo Partners LLC, Robert Flamm ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC SEC Filings - Nasdaq 的相關結果
Find the latest SEC Filings data for Cyclacel Pharmaceuticals, Inc. Common Stock ... This information can be used by investors to verify and understand the ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC Stock Price & Charts | Cyclacel Pharmaceuticals 的相關結果
In depth view into CYCC (Cyclacel Pharmaceuticals) stock including the latest price, news, ... Investor Relations URL, http://investor.cyclacel.com/. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Inc Pref Share CYCCP Stock Quote 的相關結果
See the latest Cyclacel Pharmaceuticals Inc Pref Share stock price (NASDAQ:CYCCP), related news, valuation, dividends and more to help you make your ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals, Inc. : CYCC Stock Price 的相關結果
ETFs positioned on Cyclacel Pharmaceuticals, Inc. Name. AuM. 5d. change. 1st Jan change. Investor Rating ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Roth acted as Co-Manager for Cyclacel Pharmaceuticals ... 的相關結果
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a biopharmaceutical company ... Roth Capital Partners, LLC (ROTH), is a relationship-driven investment bank ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Эмитент Cyclacel Pharmaceuticals, Inc. (91 ... - RusBonds 的相關結果
Investor relations. Документы. Отчетность. Скоринг. Связи компании. Облиг. долг млн ₽. 0. TIN91-1707622. LEI549300IE74IVYY7IL203. Информация для эмитента ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Participate in March ... - ABC4 Utah 的相關結果
Cyclacel Pharmaceuticals to Participate in March Investor Conferences ... 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC Cyclacel Pharmaceuticals, Inc. Earnings Call Transcripts 的相關結果
All earnings call transcripts on Cyclacel Pharmaceuticals, Inc. (CYCC) ... Cyclacel Pharmaceuticals (CYCC) Investor Presentation - Slideshow. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC Institutional Ownership and Shareholders - Fintel 的相關結果
Cyclacel Pharmaceuticals Inc (US:CYCC) has 34 institutional owners and ... Market Index Fund Investor Shares, and Bridgeway Capital Management Inc . ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Inc Share Price USD0.01 的相關結果
Cyclacel Pharmaceuticals Inc (CYCC) USD0.01 ... Market cap. ... Data delayed by at least 15 minutes. * To buy US shares you must first complete and return a US ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million ... 的相關結果
About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical ... Investor Relations: Grace Kim, [email protected] ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Participate in the ... - BioSpace 的相關結果
30, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ... programs at the BIO CEO & Investor Conference taking place at the New York ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Inc. SEC Filings - CYCC 的相關結果
Cyclacel Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the CYCC U.S. Securities and Exchange Commission reporting information. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals, Inc. : Actualités dans d'autres ... 的相關結果
Cyclacel Pharmaceuticals, Inc. : Actualités, news et informations Action Cyclacel ... Cyclacel Pharmaceuticals : March 2023 Corporate Presentation. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Participate in the ... - CenlaNow 的相關結果
30, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel to Present at the Oppenheimer 31st Annual ... 的相關結果
BERKELEY HEIGHTS, N.J., March 15, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Present at Biotech Showcase ... 的相關結果
15, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC, ... Investor Relations: Irina Koffler, LifeSci Advisors, LLC, ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Present ... - YourCentralValley.com 的相關結果
15, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, ... Investor Relations: Irina Koffler, LifeSci Advisors, LLC, ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Release Third Quarter 2022 ... 的相關結果
03, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Cut 28 Jobs, Take Q3 Charge 的相關結果
About Cyclacel Pharmaceuticals, Inc. Cyclacel is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism- ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals, Inc. to Host Earnings Call - AccessWire 的相關結果
Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Release Fourth Quarter and Full ... 的相關結果
27, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Announces Closing of $15.2 Million 的相關結果
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (Cyclacel or the Company), ... Existing and new investors participated in the offering. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Reports Fourth Quarter And Full ... 的相關結果
Company: Paul McBarron, (908) 517-7330, [email protected] ; Investor Relations: Irina Koffler, LifeSci Advisors, LLC, (646) 970-4681, ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Prices $12.65 Million Underwritten ... 的相關結果
BERKELEY HEIGHTS, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Announces Closing of $20 Million Public Offering 的相關結果
Contacts for Cyclacel Pharmaceuticals, Inc. Company: Paul McBarron, (908) 517-7330, [email protected]. Investor Relations: Russo Partners LLC, Jan Medina, ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC - SEC Filings - Form EFFECT Cyclacel Pharmaceuticals 的相關結果
Cyclacel Pharmaceuticals, Inc. (CYCC). Last cyclacel pharmaceuticals, inc. earnings: 2/26 04:05 pm Check Earnings Report. US:NASDAQ Investor Relations: ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Company Presentation Block- Morning Monday, February 6 的相關結果
Cyclacel Pharmaceuticals, Inc. As a clinical-stage, biopharmaceutical company, Cyclacel develops innovative cancer medicines based… ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Inc. Nouvelles et événements 的相關結果
Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update. GlobeNewswiremai 11, 2022 4:05 PM EDT. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to Participate in March Investor ... 的相關結果
BERKELEY HEIGHTS, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Actinium Pharmaceuticals Appoints Corey Sohmer As Vice ... 的相關結果
Before joining Cyclacel, he was the Senior Director of Financial Planning and ... Investor/Media Relations: Corey Sohmer, (646) 459-4201 ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel on Twitter: "Cyclacel Pharmaceuticals to present at ... 的相關結果
The Investor Relations website contains information about Cyclacel Pharmaceuticals, Inc.'s business for stockholders, potential investors, ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC Search Results - QuantumOnline.com 的相關結果
Cyclacel Pharmaceuticals, Inc. Ticker Symbol: CYCC CUSIP: 23254L405 Previous CUSIP: 23254L306 Exchange: NGM. Company's Online Profile ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals, Inc. - A Service From Broadridge 的相關結果
Generally, stockholders who have questions or concerns should contact our Investor Relations department at (908) 517-7330 or e-mail at ir@ ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals to implement 1-for-20 reverse stock ... 的相關結果
Cyclacel Pharmaceuticals Inc. said it will implement a 1-for-20 reverse split of its common stock. The Berkeley Heights, N.J.-based cancer ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel to Present at BIO Investor Forum - NBC News 的相關結果
29, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) ... Cyclacel's presentation will take place on Tuesday, ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Inc (CYCC) - Investing.com 的相關結果
View today's Cyclacel Pharmaceuticals Inc stock price and latest CYCC news and analysis. Create real-time notifications to follow any changes in the live ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals, Inc. (CYCC) Appoints Samuel L ... 的相關結果
CONTACT: Contacts for Cyclacel Pharmaceuticals, Inc. Company: Paul McBarron, (908) 517-7330, [email protected]. Investor Relations: Russo Partners LLC, ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals Announces Publication Confirming 的相關結果
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: ... Canopy Growth (NASDAQ:CGC) Investors: Losses Over $100k? ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyteir Therapeutics - Investor Relations 的相關結果
Cyteir is a clinical-stage oncology company that is focused on the development of CYT-0851, an oral investigational drug that inhibits ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC-Cyclacel Pharmaceuticals, Inc.-基本資料-美股 的相關結果
英文名稱, Cyclacel Pharmaceuticals, Inc. 交易代號, CYCC. 中文名稱, 交易所, Nasdaq. 地址, 200 Connell Drive,Berkeley Heights,New Jersey 07922,United States ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Regeneron Reports Third Quarter 2022 Financial and ... 的相關結果
3, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today ... Regeneron uses its media and investor relations website and ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 BRIEF-Cyclacel Pharmaceuticals reports Q4 revenue of ... 的相關結果
March 24 (Reuters) - Cyclacel Pharmaceuticals Inc. * Estimates it has capital resources to reach beyond final analysis of seamless and ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals - Crunchbase Company Profile ... 的相關結果
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cytokinetics, Inc.: Investor Overview 的相關結果
Corporate Presentation. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle ... ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 CYCC - Cyclacel Pharmaceuticals Inc. - The Wall Street Journal 的相關結果
View the latest Cyclacel Pharmaceuticals Inc. (CYCC) stock price, news, historical charts, analyst ratings and financial information from WSJ. ... <看更多>
cyclacel pharmaceuticals, inc investor relations 在 Cyclacel Pharmaceuticals, Inc.: Overview 的相關結果
The Investor Relations website contains information about Cyclacel Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ... ... <看更多>